- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.15: 2 residues within 4Å:- Chain A: E.177, N.178
No protein-ligand interaction detected (PLIP)NAG.16: 5 residues within 4Å:- Chain A: R.198, N.202, S.204, Q.214, N.496
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.198, A:N.496
NAG.17: 2 residues within 4Å:- Chain A: G.373, N.374
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.374
NAG.18: 3 residues within 4Å:- Chain A: Q.385, N.388, Y.395
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.385, A:Q.385
NAG.21: 1 residues within 4Å:- Chain B: N.331
No protein-ligand interaction detected (PLIP)NAG.23: 2 residues within 4Å:- Chain C: E.177, N.178
No protein-ligand interaction detected (PLIP)NAG.24: 5 residues within 4Å:- Chain C: R.198, N.202, S.204, Q.214, N.496
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.198, C:N.496
NAG.25: 2 residues within 4Å:- Chain C: G.373, N.374
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.374
NAG.26: 3 residues within 4Å:- Chain C: Q.385, N.388, Y.395
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:Q.385, C:Q.385
NAG.29: 1 residues within 4Å:- Chain D: N.331
No protein-ligand interaction detected (PLIP)- 4 x 3PH: 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE(Non-covalent)
3PH.19: 9 residues within 4Å:- Chain A: S.226, Y.229, W.473, E.476, V.477, G.480, C.483, F.487
- Chain B: I.774
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:Y.229, A:Y.229, A:W.473, A:W.473, A:V.477, A:F.487
3PH.20: 10 residues within 4Å:- Chain A: L.98, V.99, E.320, V.324, I.325, I.328, F.332, H.544, N.547, F.549
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.98, A:V.99, A:I.325, A:I.328, A:I.328, A:F.332, A:F.332, A:F.332, A:F.549
- Hydrogen bonds: A:N.547
- Salt bridges: A:H.544
3PH.27: 9 residues within 4Å:- Chain C: S.226, Y.229, W.473, E.476, V.477, G.480, C.483, F.487
- Chain D: I.774
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:Y.229, C:Y.229, C:W.473, C:W.473, C:V.477, C:F.487
3PH.28: 10 residues within 4Å:- Chain C: L.98, V.99, E.320, V.324, I.325, I.328, F.332, H.544, N.547, F.549
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:L.98, C:V.99, C:I.325, C:I.328, C:I.328, C:F.332, C:F.332, C:F.332, C:F.549
- Hydrogen bonds: C:N.547
- Salt bridges: C:H.544
- 2 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, R. et al., Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (2020)
- Release Date
- 2020-03-11
- Peptides
- Sodium-dependent neutral amino acid transporter B(0)AT1: AC
Angiotensin-converting enzyme 2: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-mer
- Ligands
- 14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 10 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x 3PH: 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE(Non-covalent)
- 2 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, R. et al., Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (2020)
- Release Date
- 2020-03-11
- Peptides
- Sodium-dependent neutral amino acid transporter B(0)AT1: AC
Angiotensin-converting enzyme 2: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CB
BD
D - Membrane
-
We predict this structure to be a membrane protein.